Cerebral Small Vessels Disease Terminated Phase 3 Trials for Atenolol (DB00335)
Also known as: Cerebral Small-vessel Disease / Cerebral Small Vessel Disease / Cerebral Small Vessel Diseases / Cerebral microangiopathy / Small vessel cerebrovascular disease (disorder) / Cerebral small vessel ischaemic disease / Cerebral small vessel ischemic disease
| Indication | Status | Phase |
|---|---|---|
| DBCOND0072196 (Cerebral Small Vessels Disease) | Terminated | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT03082014 | Effects of Amlodipine and Other Blood Pressure Lowering Agents on Microvascular Function | Treatment |